null

Crizanlizumab (Anti-SELP) Biosimilar Antibody

SKU:
HDBS0071
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
SELP
Reactivity:
Human
Host Species:
Human
Isotype:
IgG2
€373
Frequently bought together:

Description

system_update_altDatasheet

Crizanlizumab (Anti-SELP) Biosimilar Antibody (HDBS0071)

The Anti-SELPL Crizanlizu Biosimilar (HDBS0071) is a cutting-edge product designed for research purposes involving the SELPL protein. SELPL, also known as P-selectin, is a cell adhesion molecule that plays a critical role in mediating the adhesion of leukocytes to endothelial cells during inflammation. This biosimilar antibody, manufactured using advanced technology, offers high specificity and sensitivity for detecting SELPL in various samples.Developed for researchers in the fields of immunology and inflammation, the Anti-SELPL Crizanlizu Biosimilar (HDBS0071) enables precise detection and analysis of SELPL expression levels in cell types relevant to these research areas.

With its unique ability to bind selectively to SELPL, this biosimilar antibody facilitates the investigation of SELPL's involvement in immune responses and inflammatory processes.By providing researchers with a reliable tool for studying SELPL, the Anti-SELPL Crizanlizu Biosimilar (HDBS0071) holds promise for advancing our understanding of immune regulation and inflammatory diseases. Its use in studies involving conditions such as vascular inflammation and thrombosis could pave the way for the development of novel therapies targeting SELPL and its associated pathways.